REVOLADE cpr pell 25 mg 14 pce

7680601220019 CH-60122 B02BX05 06.99.0.

Reimbursement limitations:

REVOLADE.01a

Pour le traitement de première intention de l’anémie aplasique sévère (AAS) acquise en association avec …

REVOLADE cpr pell 25 mg 14 pce
REVOLADE cpr pell 25 mg 14 pce
REVOLADE cpr pell 25 mg 14 pce
1 / 3
google

Details

Product number
6012201
CPT
-
Packaging group
14
Unit
Tablette(n)
Composition
eltrombopagum 25 mg ut eltrombopagum olaminum, mannitolum, cellulosum microcristallinum, povidonum K 30, carboxymethylamylum natricum A corresp. natrium 0.784-1.176 mg, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 400, polysorbatum 80, pro compresso obducto.

Articles (1)

Revolade 25 mg, Filmtabletten
Filmtabletten
14
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
01/02/2024
Professional SmPC
Français
01/02/2024
Professional SmPC
Italien
01/02/2024
Patient information leaflet
Allemand
04/02/2022
Patient information leaflet
Français
04/02/2022
Patient information leaflet
Italien
04/02/2022

Detailed composition

Substance Quantity Type Category
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 559.10
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2010

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
60122
Drug name
Revolade, Filmtabletten
Galenic form
FILM
ATC Code
B02BX05
Authorization status
Z
Dispensation category
A
First authorization
23/06/2010
Authorization expiration date
31/12/9999
IT number
06.99.0.
Domain
Human medicine
Field of application
Zur Behandlung von erwachsenen Patienten mit (idiopathischen) immunthrombozytopenischen Purpura (ITP), die auf andere Therapieoptionen (z.B. Kortikosteroide, Immunglobuline oder Splenektomie) nicht genügend ansprachen, bei erhöhtem Blutungsrisiko infolge ausgeprägter Thrombozytopenie

Packaging details

Description (FR)
REVOLADE cpr pell 25 mg 14 pce
Description (DE)
REVOLADE Filmtabl 25 mg 14 Stk
Market launch
23/06/2010
Narcotic (BTM)
No

Other packaging sizes

REVOLADE cpr pell 25 mg 28 pce
28 TABL
GTIN: 7680601220026
View
REVOLADE cpr pell 50 mg 14 pce
14 TABL
GTIN: 7680601220033
View
REVOLADE cpr pell 50 mg 28 pce
28 TABL
GTIN: 7680601220040
View
REVOLADE cpr pell 12.5 mg 14 pce
14 TABL
GTIN: 7680601220057
View
REVOLADE cpr pell 75 mg 28 pce
28 TABL
GTIN: 7680601220064
View